NFKB1 and type 2 diabetes mellitus: NF-kB inflammatory signaling is implicated in the development of T2DM (Baker, Hayden & Ghosh, 2011) and experimental evidence shows interfering with NF-kB signaling can decrease hyperglycemia and insulin resistance.